Clinical Trials

Underrepresented in cancer clinical trials, racial and ethnic minorities often miss out on the benefits of research participation. Educating potential participants on clinical trials can increase enrollment among populations that have been commonly overlooked.
September 2019 Vol 10, No 9 | September 9, 2019
Adolescent and young adult (AYA) patients aged 15 to 39 years are significantly underrepresented in cancer clinical trials.
May 2019 Vol 10, No 5 | May 8, 2019
Darolutamide, an investigational androgen receptor inhibitor, significantly improved metastasis-free survival in men with high-risk nonmetastatic castration-resistant prostate cancer (CRPC) compared with placebo in a large phase 3 clinical trial.
October 2018 Vol 9, NO 10 | October 11, 2018
Dr James provides a review of recent report from the American Cancer Society Cancer Action Network on barriers to patient enrollment in therapeutic clinical trials for cancer and the consensus recommendations for overcoming these challenges.
September 2018 Vol 9, No 9 | September 17, 2018
Nurse and patient navigators are uniquely qualified to advocate for minority participation in oncology clinical trials.
August 2018 Vol 9, No 8 | August 14, 2018
Patient navigators are increasingly recognized for their critical role in helping patients make their way through complex healthcare systems, all the way from screening to treatment adherence. Clinical trials are a vital part of high-quality cancer care, and navigators have become invaluable in facilitating patient awareness and access to trials, while also normalizing the clinical trial process and dispelling myths.
Video Library | July 2, 2018
Danielle Carnival believes that providing patients with the most up-to-date tools and resources about clinical trials is an essential part of doubling the rate of progress in the fight against cancer, and the Biden Cancer Initiative is focused on reaching a wide range of patients with this information.
April 2018 Vol 9, No 4 | April 10, 2018
Ms Shockney discusses the importance of clinical trials and extends an invitation to apply to the AONN+ Clinical Trials Committee.
April 2018 Vol 9, No 4 | April 10, 2018
The co-chairs of the AONN+ Clinical Trials Committee discuss the roles of navigators and researchers in clinical trials, barriers to clinical trials that navigators can mitigate, and helpful tips and talking points to consider when talking about clinical trials with patients.
Page 1 of 2
Results 1 - 10 of 19

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
    Profession or Role
    Primary Specialty or Disease State
  • Please enter your mailing address.

    Address Line 2
    Zip Code